Cunnea P

ORCID: 0000-0002-3699-4911 · 3 papers in corpus
meta-analysis 2026
International journal of molecular sciences ·doi:10.3390/ijms27198823

Ovarian cancer (OC) is the most lethal gynecological malignancy, largely because non-specific symptoms contribute to advanced-stage diagnosis and poor prognosis, underscoring the need for improved non-invasive biomarkers. Circulating microR…

review 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.837233

Epithelial ovarian cancer (EOC) is a heterogenous disease associated with variations in presentation, pathology and prognosis. Advanced EOC is typified by frequent relapse and a historical 5-year survival of less than 30% despite improvemen…

review 2021
Cancers ·doi:10.3390/cancers13133349

Gynaecological malignancies represent a heterogeneous group of neoplasms with vastly different aetiology, risk factors, molecular drivers, and disease outcomes. From HPV-driven cervical cancer where early screening and molecular diagnostics…